Jacob Draxler, Product Development Engineer, Cardiovascular Systems Inc
Joseph P. Higgins, Director of Technology and Product Development, Cardiovascular Systems Inc
Vascular atherectomy and interventional medicine has resulted in improved clinical outcomes for 20 plus years. Through the development of new tools and techniques for treating patients, proper disease recreations have not been available in a repeatable and reproducible manner. With the introduction and combination of multi colored, multi material, and high resolution 3D printers you are now able to create, print, and treat complex disease. Not only can one now see macro process of material removal, you can now dial in the model and the devices to even see the micro impact of material changes, anatomical variation, and device changes. In this study we show the development, progression, and deployment of 3D printed ablation and wear models for the development, iteration, and training for these types of material removal and modification devices.
Cardiovascular Systems Inc
Jacob Draxler, Product Development Engineer, received Masters Deg